Antiparkinsonian effect of nerve growth factor adsorbed on polybutylcyanoacrylate nanoparticles coated with polysorbate-80

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 2, 2008, Pages 259-262

  Kurakhmaeva, K B ^b   Voronina, T A ^b   Kapica, I G ^a   Kreuter, J ^c   Nerobkova, L N ^b   Seredenin, S B ^a   Balabanian, V Yu ^a   Alyautdin, R N ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Nerve growth factor; Parkinsoniandisease; Polybutylcyanoacrylatenanoparticles coated with polysorbate 80

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; NANOPARTICLE; NERVE GROWTH FACTOR; POLY(BUTYL 2 CYANOACRYLATE); POLYSORBATE 80;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; LOCOMOTION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PARKINSONISM; RIGIDITY; TREATMENT RESPONSE;

ADSORPTION; ANIMALS; ANTIPARKINSON AGENTS; BLOOD-BRAIN BARRIER; DRUG CARRIERS; ENBUCRILATE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NANOPARTICLES; NERVE GROWTH FACTOR; PARKINSONIAN DISORDERS; POLYSORBATES; SURFACE-ACTIVE AGENTS;

MUS; PARKINSONIA;

EID: 50649103475     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0065-y     Document Type: Article

References (15)

1. A. A. Bassel, V. E. Petrov, S. S. Trofimov, et al., Eksp. Klin. Farmakol., 68, No. 6, 3-8 (2005).
2. T. A. Voronina, E. A. Val'dman, and L. N. Nerobkova, Textbook on Experimental (Preclinical) Study of Novel Pharmacological Substances, Ed. R. U. Khabriev [in Russian], Moscow (2005), pp. 295-307.
3. A. Blöchl and C. Sirrenberg, J. Biol. Chem., 271, No. 35, 21,100-21,107 (1996).
4. A. Brancucci, N. Kuczewski, S. Covaceuszach, et al., J. Physiol., 559, 497-506 (2004).
5. R. K. Chaturvedi, S. Shukla, K. Seth, and A. K. Agrawal, Neurosci. Lett., 398, Nos. 1-2, 44-49 (2006).
6. K. Eggert, J. Schlegel, W. Oertel, et al., Ibid., 269, No. 3, 178-182 (1999).
7. S. M. Fernandez and K. M. Frick, Behav. Neurosci., 118, No. 6, 1340-1351 (2004).
8. E. Garcia, C. Rios, and J. Sotelo, Neurochemical Res., 17, No. 10, 979-982 (1992).
9. S. E. Gelperina, A. S. Khalansky, I. N. Skidana, et al., Toxicol. Lett., 126, No. 2, 131-141 (2002).
10. M. Gerlach and P. Riederer, J. Neural. Transm., 103 Nos. 8-9, 987-1041 (1996).
11. C. Humpel and C. Weis, Ibid., 62, Suppl., 253-263 (2002).
12. P. Ramge, R. E. Unger, J. B. Oltrogge, et al., Eur. J. Neurosci., 12, No. 6, 1931-1940 (2000).
13. N. Schmidt and B. Ferger, J. Neural. Transm., 108, 1263-1282 (2001).
14. W. Sun, C. Xie, H. Wang, and Y. Íu, Biomaterials, 25, No. 15, 3065-3071 (2004).
15. H. Thoenen and M. Sendtner, Nat. Neurosci., 5, Suppl., 1046-1050 (2002).